With a mRNA vaccine finally in trials, will China change its Covid approach?
China may be set to take a major step towards catching up with Western nations in the global vaccine race. Whether that will lead Beijing to change its stringent approach to the pandemic is still open to doubt.
In November, Suzhou Abogen Biosciences and two partners — Yunnan-based Walvax Biotechnology and the Chinese Academy of Military Medical Sciences — received approval from the Chinese authorities to test its new ARCoVax vaccine in a booster trial. If it proves effective, ARCoVax woul
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from David Barboza, Pulitzer Prize-winning former Shanghai correspondent for The New York Times.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
What is so hard about making chips in America? And can the U.S. do anything about it? As part of his series, 'Remaking the Chain,' Luke Patey went searching for answers from America's past and from the last country to threaten its mantle as the world’s leading economy.
The political scientist and sinologist talks about the early days of the pandemic in Wuhan, and how the Chinese authorities’ lack of transparency led the virus to spread rapidly.
A podcast about how the two nations, once friends, are now foes.
Hear why things are so complicated now. Host Jane Perlez, former New York Times Beijing bureau chief, talks with diplomats, spies, cultural superstars like Yo Yo Ma, and more to understand why the dangers are so high, and why relations went awry.